Kenvue (NYSE:KVUE) rose 6.6% in after hours trading after a court ruled in it favor in a class action lawsuit alleging prenatal exposure to Tylenol
https://seekingalpha.com/news/4047710-kenvue-gains-after-court-victory-in-case-over-tylenol-purported-links-to-autism
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.